Search

Claudio Bertuccioli

from Brooklyn, NY
Get Report
Also known as:
Claudio I
Related to:
John Graham, 59Thomas GrahamMichael ArenstamMargaret Arenstam
Connected to:
Andrea M Bertucci, 54Ashleigh Bertucci, 38Caterina F Bertucci, 43Cynthia A Bertuca, 68Elise L Bertucci, 35Enrico J Bertucci, 39Julie A Bertuccelli, 66Karina Bertucci, 70Maria Bertucci, 63Mary D Bertucci, 61

Claudio Bertuccioli Phones & Addresses

  • Brooklyn, NY
  • Oakland, MD
  • San Francisco, CA
  • Palo Alto, CA
  • New York, NY

Work

Company: Bgb group Dec 2019 Position: Medical director

Skills

Start Ups • Due Diligence • Biotechnology • Business Development • Investments • Management Consulting • Lifesciences • Pharmaceutical Industry • Medical Devices • Portfolio Management • Fundraising • Corporate Development • Angel Investing • Private Equity • Finance • Financial Modeling • Venture Financing • Valuation • Negotiation • Venture Capital • Protein Chemistry • Entrepreneurship • Commercialization • Strategic Partnerships • Licensing • Business Planning • Acquisition Integration • Life Sciences • Emerging Markets • Strategy

Languages

Italian • German • French

Industries

Biotechnology

Resumes

Resumes

Claudio Bertuccioli Photo 1

Medical Director

View page
Location:
Brooklyn, NY
Industry:
Biotechnology
Work:
Bgb Group
Medical Director
Skills:
Start Ups
Due Diligence
Biotechnology
Business Development
Investments
Management Consulting
Lifesciences
Pharmaceutical Industry
Medical Devices
Portfolio Management
Fundraising
Corporate Development
Angel Investing
Private Equity
Finance
Financial Modeling
Venture Financing
Valuation
Negotiation
Venture Capital
Protein Chemistry
Entrepreneurship
Commercialization
Strategic Partnerships
Licensing
Business Planning
Acquisition Integration
Life Sciences
Emerging Markets
Strategy
Languages:
Italian
German
French

Publications

Us Patents

Conformationally Stabilized Rsv Pre-Fusion F Proteins

View page
US Patent:
20190292228, Sep 26, 2019
Filed:
Oct 9, 2018
Appl. No.:
16/155857
Inventors:
- NEW YORK NY, US
- BETHESDA MD, US
Peter Joseph Alff - New York NY, US
Claudio Bertuccioli - New York NY, US
Roberto Mariani - San Diego CA, US
Assignee:
CALDER BIOSCIENCES INC. - NEW YORK NY
THE UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HELATH - BETHESDA MD
International Classification:
C07K 14/005
A61K 39/155
A61K 39/12
Abstract:
In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.

Influenza Hemagglutinin Proteins And Methods Of Use Thereof

View page
US Patent:
20180243403, Aug 30, 2018
Filed:
Dec 22, 2017
Appl. No.:
15/852208
Inventors:
- New York NY, US
Peter Joseph Alff - New York NY, US
Claudio Bertuccioli - New York NY, US
Mark Andrew Yondola - Medford NY, US
International Classification:
A61K 39/145
C12N 7/00
C07K 14/005
A61K 45/06
Abstract:
In some embodiments the present invention provides influenza hemagglutinin (“HA”) polypeptides, proteins, and protein complexes that comprise a stalk domain that is engineered to facilitate maintenance of its native trimeric conformation, even if the head domain of the HA protein is removed or disrupted. In some embodiments, the present invention provides compositions comprising such polypeptides, proteins, and protein complexes, and methods of use of such proteins and compositions, for example as vaccine immunogens.

Influenza Hemagglutinin Proteins And Methods Of Use Thereof

View page
US Patent:
20170072045, Mar 16, 2017
Filed:
Jun 15, 2016
Appl. No.:
15/182958
Inventors:
- New York NY, US
Peter Joseph Alff - New York NY, US
Claudio Bertuccioli - New York NY, US
Mark Andrew Yondola - Medford NY, US
International Classification:
A61K 39/145
C12N 7/00
C07K 14/005
Abstract:
In some embodiments the present invention provides influenza hemagglutinin (“HA”) polypeptides, proteins, and protein complexes that comprise a stalk domain that is engineered to facilitate maintenance of its native trimeric conformation, even if the head domain of the HA protein is removed or disrupted. In some embodiments, the present invention provides compositions comprising such polypeptides, proteins, and protein complexes, and methods of use of such proteins and compositions, for example as vaccine immunogens.

Influenza Hemagglutinin Proteins And Methods Of Use Thereof

View page
US Patent:
20150056233, Feb 26, 2015
Filed:
Aug 2, 2014
Appl. No.:
14/450236
Inventors:
Christopher Patrick Marshall - New York NY, US
Peter Joseph Alff - New York NY, US
Claudio Bertuccioli - New York NY, US
Mark Andrew Yondola - Medford NY, US
International Classification:
A61K 39/145
C12N 7/00
A61K 45/06
C07K 14/005
US Classification:
4241861, 530396, 536 2372
Abstract:
In some embodiments the present invention provides influenza hemagglutinin (“HA”) polypeptides, proteins, and protein complexes that comprise a stalk domain that is engineered to facilitate maintenance of its native trimeric conformation, even if the head domain of the HA protein is removed or disrupted. In some embodiments, the present invention provides compositions comprising such polypeptides, proteins, and protein complexes, and methods of use of such proteins and compositions, for example as vaccine immunogens.

Conformationally Stabilized Rsv Pre-Fusion F Proteins

View page
US Patent:
20150030622, Jan 29, 2015
Filed:
Jul 24, 2014
Appl. No.:
14/340519
Inventors:
Christopher Patrick Marshall - New York NY, US
Jason Scott McLellan - Norwich VT, US
Peter Joseph Alff - New York NY, US
Claudio Bertuccioli - New York NY, US
Roberto Mariani - San Diego CA, US
International Classification:
C07K 14/005
A61K 39/155
US Classification:
4241861, 530350, 536 2372
Abstract:
In some embodiments, the present invention provides respiratory syncytial virus (RSV) F proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides RSV F proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking. In some embodiments the present invention provides compositions comprising such proteins, polypeptides or protein complexes, including vaccine compositions, and methods of making and using the same.
Control profile
Claudio Bertuccioli from Brooklyn, NY Get Report